ETOPOSIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Etoposide, and what generic alternatives are available?
Etoposide is a drug marketed by Mylan, Accord Hlthcare, Dash Pharms, Dash Pharms Natco, Fresenius Kabi Usa, Hikma, Hospira, Meitheal, Pharmachemie Bv, Pierre Fabre, Teva Parenteral, Teva Pharms Usa, Watson Labs, and Watson Labs Inc. and is included in fifteen NDAs.
The generic ingredient in ETOPOSIDE is etoposide. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the etoposide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Etoposide
A generic version of ETOPOSIDE was approved as etoposide by HIKMA on July 17th, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ETOPOSIDE?
- What are the global sales for ETOPOSIDE?
- What is Average Wholesale Price for ETOPOSIDE?
Summary for ETOPOSIDE
| US Patents: | 0 |
| Applicants: | 14 |
| NDAs: | 15 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 90 |
| Clinical Trials: | 1,601 |
| Patent Applications: | 2,711 |
| Drug Prices: | Drug price information for ETOPOSIDE |
| DailyMed Link: | ETOPOSIDE at DailyMed |
Recent Clinical Trials for ETOPOSIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Vanderbilt-Ingram Cancer Center | Phase 1/Phase 2 |
| Genentech, Inc. | Phase 1/Phase 2 |
| Vanderbilt-Ingram Cancer Center | Phase 2 |
Pharmacology for ETOPOSIDE
| Drug Class | Topoisomerase Inhibitor |
| Mechanism of Action | Topoisomerase Inhibitors |
Medical Subject Heading (MeSH) Categories for ETOPOSIDE
Anatomical Therapeutic Chemical (ATC) Classes for ETOPOSIDE
US Patents and Regulatory Information for ETOPOSIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan | ETOPOSIDE | etoposide | CAPSULE;ORAL | 075635-001 | Sep 19, 2001 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | ETOPOSIDE | etoposide | INJECTABLE;INJECTION | 074320-001 | Aug 30, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dash Pharms Natco | ETOPOSIDE | etoposide | INJECTABLE;INJECTION | 203507-001 | Nov 20, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Parenteral | ETOPOSIDE | etoposide | INJECTABLE;INJECTION | 074510-001 | Jun 29, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
